BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11697488)

  • 1. Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.
    Molica S
    Leuk Lymphoma; 2001 Aug; 42(4):603-7. PubMed ID: 11697488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
    Molica S; Vacca A; Ribatti D; Cuneo A; Cavazzini F; Levato D; Vitelli G; Tucci L; Roccaro AM; Dammacco F
    Blood; 2002 Nov; 100(9):3344-51. PubMed ID: 12384436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells.
    Chen H; Treweeke AT; West DC; Till KJ; Cawley JC; Zuzel M; Toh CH
    Blood; 2000 Nov; 96(9):3181-7. PubMed ID: 11050001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.
    Kini AR; Kay NE; Peterson LC
    Leukemia; 2000 Aug; 14(8):1414-8. PubMed ID: 10942237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L; Kasparová P
    APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
    Kasparová P; Smolej L
    Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Wozniak Z; Potoczek S; Ganczarski G; Wrobel T; Kuliczkowski K; Frydecka I; Jeleń M
    Anal Quant Cytol Histol; 2004 Oct; 26(5):263-70. PubMed ID: 15560532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in B-chronic lymphocytic leukemia.
    Kay NE; Jelinek DF; Peterson L
    Leuk Res; 2001 Jun; 25(6):485-6. PubMed ID: 11337021
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis in B-chronic lymphocytic leukemia.
    Kay NE; Jelinek DF; Peterson L
    Leuk Res; 2001 Aug; 25(8):709-10. PubMed ID: 11397477
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
    Aguayo A; O'Brien S; Keating M; Manshouri T; Gidel C; Barlogie B; Beran M; Koller C; Kantarjian H; Albitar M
    Blood; 2000 Jul; 96(2):768-70. PubMed ID: 10887147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE
    Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis is increased in B-cell chronic lymphocytic leukemia.
    Peterson L; Kini AR
    Blood; 2001 Apr; 97(8):2529. PubMed ID: 11307777
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
    Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
    Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in acute and chronic leukemias.
    Dickson DJ; Shami PJ
    Leuk Lymphoma; 2001; 42(5):847-53. PubMed ID: 11697639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Gandolfo GM; Liso V
    Br J Haematol; 1999 Dec; 107(3):605-10. PubMed ID: 10583266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Jamroziak K; Szmigielska-Kaplon A; Krawczynska A; Lech-Maranda E; Wierzbowska A; Jesionek-Kupnicka D; Blonski JZ; Robak T
    Leuk Lymphoma; 2009 Jan; 50(1):62-7. PubMed ID: 19125384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells.
    Molica S; Santoro R; Digiesi G; Dattilo A; Levato D; Muleo G
    Haematologica; 2000 Oct; 85(10):1106-8. PubMed ID: 11025612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vascular endothelial growth factor VEGF stimulates angiogenesis in good and bad situations].
    Heits F; Wiedemann GJ; Jelkmann W
    Dtsch Med Wochenschr; 1998 Feb; 123(9):259-65. PubMed ID: 9524537
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Ricciotti A; Digiesi G
    Br J Cancer; 2002 Jan; 86(1):31-5. PubMed ID: 11857008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.